11
Marlene L Cohen, William B Lacefield, David W Robertson: 5-halo-2,3-dihydro-2,2-dimethylbenzofuran-7-carboxylic acids useful as intermediates for 5-HT.sub.3 antagonists. Eli Lilly and Company, Robert A Conrad, Leroy Whitaker, May 1, 1990: US04921982 (14 worldwide citation)

This invention provides bicyclic carboxylic esters and amides, their pharmaceutical formulations, and a method for their use in treating migraine, emesis, gastrointestinal disorders, schizophrenia, or anxiety in mammals.


12

13
Marlene L Cohen, David W Robertson: N-(2-hydroxycyclopentyl)-1-isopropyl-6-methylergoline-8-carboxamides. Eli Lilly and Company, Robert A Conrad, Leroy Whitaker, August 27, 1991: US05043341 (14 worldwide citation)

This invention provides N-(2-hydroxycyclopentyl)-1-isopropyl-6-methylergoline-8-carboxamides useful for blocking 5HT.sub.2 receptors in mammals having an excess of serotonin centrally or peripherally. The invention also provides methods for treating sexual dysfunction, hypertension, migraine, vasosp ...


14
Edward E Beedle, David W Robertson, David T Wong: Cycloalkylaminoalkoxyindoles. Eli Lilly and Company, Joseph A Jones, May 30, 1995: US05420294 (12 worldwide citation)

This invention provides a method of selectively antagonizing the 5-HT.sub.1A receptor in mammals by administering aryloxypropanolamines. Aryloxypropanolamines are also claimed.


15
Ray W Fuller, David Mitchell, David W Robertson, Gregory A Stephenson, David T Wong: (S)-norfluoxetine in method of inhibiting serotonin uptake. Eli Lilly and Company, Joseph A Jones, Leroy Whitaker, Robert A Conrad, October 5, 1993: US05250571 (12 worldwide citation)

The present invention provides (S)-norfluoxetine and pharmaceutically acceptable salts thereof capable of inhibiting the uptake of serotonin.


16
Donald R Gehlert, David W Robertson, David T Wong: N-alkyl-3-phenyl-3-(2-substituted phenoxy) propylamines and pharmaceutical use thereof. Eli Lilly and Company, Joseph A Jones, Leroy Whitaker, January 25, 1994: US05281624 (10 worldwide citation)

This invention provides N-alkyl-3-phenyl-3-(2-substituted phenoxy)propylamines which are useful to treat neurological disorders associated with norepinephrine imbalance.


17
Edward E Beedle, David W Robertson: Anticonvulsant agents. Eli Lilly and Company, Robert A Conrad, Arthur R Whale, December 30, 1986: US04632939 (10 worldwide citation)

This invention provides certain benzamide derivatives of the formula: ##STR1## wherein Z is bond, --CH.sub.2 --, or CHCH.sub.3 ; A is --CH.sub.2 --, or CH.sub.2 CH.sub.2 --; and represents a single or double bond; and their pharmaceutical formulations and their use as anticonvulsant agents.


18
William R Little, Jason W Kear, David W Robertson, James Teague, James W Riley: Medical retrieval device with frangible basket. Scimed Life Systems, Finnegan Henderson Farabow Garrett & Dunner L, March 16, 2010: US07678119 (9 worldwide citation)

An embodiment of a medical retrieval device includes a sheath having a proximal end and a distal end, a handle at the proximal end of the sheath, and a basket. The basket has a collapsed position when the basket is within the sheath and collapsed and an expanded position when the basket is positione ...


19
Marlene L Cohen, David W Robertson: Heteroalkylamides of (8-.beta.)-1-alkyl-6-(substituted)ergolines useful for blocking 5HT.sub.2 receptors. Eli Lilly and Company, Robert A Conrad, Leroy Whitaker, February 20, 1990: US04902691 (9 worldwide citation)

This invention provides (8.beta.)-N-heteroalkyl-1-alkyl-6-(substituted)ergoline-8-carboxamides useful for blocking 5HT.sub.2 receptors in mammals having an excess of serotonin centrally or peripherally. The invention also provides methods for treating sexual dysfunction, hypertension, migraine, vaso ...


20
David W Robertson: Pyridazinone derivatives as inotropic agents. Eli Lilly and Company, Charles W Ashbrook, Arthur R Whale, May 27, 1986: US04591591 (8 worldwide citation)

This invention provides for the use of certain pyridazinones as positive inotropic agents.